-

Outcome Capital Announces Partnership of ZIEN Medical and Averra Holdings

Outcome Capital served as exclusive strategic and financial advisor to ZIEN

BOSTON--(BUSINESS WIRE)--Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that ZIEN Medical Technologies (“ZIEN”), a medical device contract design and manufacturing organization, has entered into a partnership with Averra Holdings, LLC, (“Averra”), a provider of specialized packaging solutions with a focus on the medical device industry and a portfolio company of Banner Capital.

"By combining ZIEN’s engineering excellence with Averra’s specialized packaging solutions, we are enhancing the value proposition for clients and supporting the advancement of innovation." - Dr. Oded Ben Joseph, Managing Partner at Outcome Capital

Share

“Outcome Capital’s deep insight and counsel played a key role in guiding us to combine services and achieve this successful transaction,” said Tim Nieman, CEO of ZIEN. “As part of Averra, ZIEN's capabilities will be enhanced to include vertically integrated design and manufacturing services. Our team is eager to integrate and grow our impact.”

Thomas Busby, Director at Outcome Capital, commented, "ZIEN and Averra have tremendous tailwinds with renewed interest in domestic manufacturing, high demand for vertically integrated services, and a tailored platform for medtech companies to turn to. This is a win not only for ZIEN and Averra but for the medtech community."

Dr. Oded Ben Joseph, Managing Partner at Outcome Capital, added, “This collaboration represents a strategic step forward for both organizations. By combining ZIEN’s engineering excellence with Averra’s specialized packaging solutions, we are enhancing the value proposition for clients and supporting the advancement of innovative medical technologies. Outcome Capital is proud to have guided this partnership, leveraging our deep industry expertise to help both companies realize their shared vision for growth and impact in the medtech sector.”

About Outcome Capital

Outcome Capital (outcomecapital.com) is a highly specialized life sciences and healthcare advisory and investment banking firm, providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering and corporate finance. The firm leverages its proven ‘strategy-led execution’ approach to value enhancement by assisting management teams and their boards in navigating both financial and corporate markets and implementing the best path for success. The firm’s strength stems from its multi-disciplinary, industry experts who draw from their broad relationships and a wide range of scientific, operational, strategic and transactional expertise across the value chain. Comprised of former CEOs, business development executives, venture capitalists, PhD/MD-level scientists and clinicians, and experienced commercialization experts, Outcome’s team is driven to propel innovation from bench to bedside.

About ZIEN Medical

Founded in 2009 and based in Salt Lake City, ZIEN is a vertically integrated medical device contract design & manufacturing organization (CDMO) providing product design & development, manufacturing, cost-down, packaging, sterilization, and quality & regulatory services to medical device companies.

About Averra Packaging

Founded in 1989, Averra Packaging is a leading provider of packaging solutions, specializing in the manufacturing of thermoformed packaging and flexible packaging, as well as packaging fulfillment services. Averra Packaging is focused on serving the medical device space while also providing packaging for the industrial, food, retail, and cosmetic industries. Featuring full in-house design, development, prototyping, tooling, and production capabilities, Averra Packaging specializes in innovative packaging solutions for companies around the world. Averra is headquartered in Salt Lake City, Utah.

Contacts

Outcome Capital - Media
Michelle Linn
Linnden Communications
michelle@linndencom.com

Outcome Capital
Steve Holstein
SHolstein@outcomecapital.com

Outcome Capital, LLC


Release Summary
Highly specialized life sciences and healthcare advisory and investment banking firm supports medical device organization ZIEN execute partnership.
Release Versions

Contacts

Outcome Capital - Media
Michelle Linn
Linnden Communications
michelle@linndencom.com

Outcome Capital
Steve Holstein
SHolstein@outcomecapital.com

Social Media Profiles
More News From Outcome Capital, LLC

Outcome Capital Launches Pharmacy and Related Services Advisory Board to Advance Innovation Across the Healthcare Sector

BOSTON--(BUSINESS WIRE)--Outcome's new Advisory Board to provide strategic insight and specialized expertise to pharmaceutical, pharmacy, and related service provider clients...

Outcome Capital Launches Dedicated Healthcare Services Practice to Expand Strategic Advisory and Investment Banking Capabilities

BOSTON--(BUSINESS WIRE)--Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced the launch of its Healthcare Services Practice, expanding the firm’s strategic and transactional advisory capabilities to meet the needs of companies operating across the rapidly evolving healthcare services sector. Building on the success of Outcome Capital’s Ophthalmology Practice, the first dedicated investment banking group serving the eye ca...

Outcome Capital Launches the First Dedicated Ophthalmology Practice to Address the World’s Leading Cause of Disability

BOSTON--(BUSINESS WIRE)--Outcome Capital, LLC, today announced that Paul Ryb has been appointed Managing Director and will lead the firm’s dedicated ophthalmology practice....
Back to Newsroom